INVO Fertility, Inc.
Calidad de datos: 100%
IVF
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$2.00
▼
$0.06
(-2.91%)
Cap. Mercado: 13.92 M
Precio
$2.00
Cap. Mercado
13.92 M
Rango del Día
$1.93 — $2.09
Rango de 52 Semanas
$1.93 — $384.00
Volumen
47,862
Apertura $2.06
Promedio 50D / 200D
$4.67
57.21% below
Promedio 50D / 200D
$32.59
93.86% below
Quick Summary
Puntos Clave
Revenue grew 58.41% annually over 5 years — strong growth
Debt/Equity of 0.34 — conservative balance sheet
Negative free cash flow of -7.77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 57.84%
Capital efficient — spends only 1.59% of revenue on capex
Crecimiento
Revenue Growth (5Y)
58.41%
Above sector avg (9.35%)
Revenue (1Y)116.25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-682.92%
Below sector avg (-51.02%)
ROIC-94.17%
Net Margin-417.01%
Op. Margin-141.14%
Seguridad
Debt / Equity
0.34
Above sector avg (0.33)
Current Ratio0.12
Interest Coverage-10.81
Valoración
PE (TTM)
-0.48
Above sector avg (-1.98)
P/B Ratio2.38
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.5 | -2.0 |
| P/B | 2.4 | 5.1 |
| ROE % | -682.9 | -51.0 |
| Net Margin % | -417.0 | -150.2 |
| Rev Growth 5Y % | 58.4 | 9.3 |
| D/E | 0.3 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 116.25% | Revenue Growth (3Y) | 181.86% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58.41% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6.94 M | Net Income (TTM) | -28.96 M |
| ROE | -682.92% | ROA | -151.80% |
| Gross Margin | N/A | Operating Margin | -141.14% |
| Net Margin | -417.01% | Free Cash Flow (TTM) | -7.77 M |
| ROIC | -94.17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.34 | Current Ratio | 0.12 |
| Interest Coverage | -10.81 | Asset Turnover | 0.36 |
| Working Capital | -8.11 M | Tangible Book Value | -1.46 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.48 | Forward P/E | N/A |
| P/B Ratio | 2.38 | P/S Ratio | 2.00 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -55.79% | ||
| Market Cap | 13.92 M | Enterprise Value | 15.90 M |
| Per Share | |||
| EPS (Diluted TTM) | -46.38 | Revenue / Share | 1.00 |
| FCF / Share | -1.12 | OCF / Share | -1.10 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.59% | FCF Conversion | 26.82% |
| SBC-Adj. FCF | N/A | Growth Momentum | 57.84 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6.53 M | 3.02 M | 822,196.0 | 4.16 M | 1.04 M |
| Net Income | -9.10 M | -8.03 M | -10.89 M | -6.65 M | -8.35 M |
| EPS (Diluted) | -30.19 | -5.13 | -0.90 | -0.63 | -1.52 |
| Gross Profit | — | — | 490,673.0 | 4.02 M | 948,526.0 |
| Operating Income | -8.13 M | -6.77 M | -10.63 M | -5.22 M | -5.51 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 489,660.0 | 165,945.0 | 544,043.0 | 216,430.0 | 398,426.0 |
| SG&A Expenses | 9.08 M | 7.49 M | 10.57 M | 9.02 M | 6.07 M |
| D&A | 919,603.0 | 200,894.0 | 77,301.0 | 27,760.0 | 11,917.0 |
| Interest Expense | 1.06 M | 925,909.0 | 59,445.0 | 1.27 M | 2.84 M |
| Income Tax | -22,913.0 | 27,786.0 | 2,872.0 | 4,764.0 | 36.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 46.45 M | 20.89 M | 4.10 M | 10.47 M | 10.95 M |
| Total Liabilities | 26.24 M | 19.99 M | 5.08 M | 3.16 M | 5.20 M |
| Shareholders' Equity | 12.75 M | 892,825.0 | -977,612.0 | 7.31 M | 5.74 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | — | 5.68 M | 10.10 M |
| Current Assets | 1.32 M | 1.26 M | 621,087.0 | 6.31 M | 10.54 M |
| Current Liabilities | 17.93 M | 8.22 M | 3.41 M | 1.25 M | 2.29 M |
{"event":"ticker_viewed","properties":{"ticker":"IVF","listing_kind":"stock","pathname":"/stocks/ivf","exchange":"Nasdaq","country":"US"}}